Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ONYX PHARMACEUTICALS INC (ONXX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/01/2013 8-K Quarterly results
08/26/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among Onyx Pharmaceuticals, Inc., Amgen Inc. and Arena Acquisition Company",
"AMGEN TO ACQUIRE ONYX PHARMACEUTICALS FOR $125 PER SHARE IN CASH"
08/08/2013 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports Second Quarter 2013 Financial Results"
07/31/2013 8-K Results of Operations and Financial Condition
07/01/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Investors: Amy Figueroa 266-2398 2"
05/07/2013 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports First Quarter 2013 Financial Results"
04/25/2013 8-K Results of Operations and Financial Condition
03/11/2013 8-K Regulation FD Disclosure
02/21/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2012 Financial Results"
01/07/2013 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference"
11/01/2012 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results"
09/27/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Intended for U.S. Media Only Bayer's Stivarga® Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer"
08/01/2012 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results"
07/31/2012 8-K Results of Operations and Financial Condition
07/20/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis ™ for Injection"
05/22/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "(i)"
05/02/2012 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports First Quarter 2012 Financial Results"
04/26/2012 8-K Results of Operations and Financial Condition
02/22/2012 8-K Form 8-K - Current report
02/16/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/18/2011 8-K Form 8-K - Current report
11/02/2011 8-K Form 8-K - Current report
10/27/2011 8-K Other Events
08/03/2011 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results"
07/28/2011 8-K Form 8-K - Current report
05/27/2011 8-K Form 8-K - Current report
05/18/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "(ii)+",
"(ii)+"
05/04/2011 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports First Quarter 2011 Financial Results"
04/28/2011 8-K Form 8-K - Current report
02/23/2011 8-K Form 8-K - Current report
02/04/2011 8-K Form 8-K - Current report
02/02/2011 8-K Form 8-K - Current report
12/22/2010 8-K Form 8-K - Current report
11/03/2010 8-K Quarterly results
Docs: "Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy